Psychosocial Impact of the Bionic Pancreas during Summer Camp

Journal of Diabetes Science and Technology

Volumn 10, Issue 4, 2016, Pages 840-844

  Weissberg Benchell, Jill ^a   Hessler, Danielle ^b   Polonsky, William H ^c   Fisher, Lawrence ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Behavioral Diabetes Institute   (United States)

Author keywords

artificial pancreas; automated insulin delivery; bionic pancreas; diabetes camp; psychosocial

Indexed keywords

GLUCAGON; HEMOGLOBIN A1C;

ARTICLE; CHILD; CLINICAL ARTICLE; DIABETES MELLITUS; EMOTIONAL STRESS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; MALE; OUTCOME ASSESSMENT; SOCIAL PSYCHOLOGY; VISUAL PROSTHESIS; ARTIFICIAL PANCREAS; BLOOD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS, TYPE 1; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PANCREAS, ARTIFICIAL;

EID: 85009264108     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816640289     Document Type: Article

References (26)

1. Haidar A, Legault L, Messier V, Mitre T, Leroux C, Rabase-Lhorel R., Comparison of dual-hormone artificial pancreas, single hormone artificial pancreas, and conventional insulin pump therapy for glycemic control in patients with type 1 diabetes. Lancet Diabetes Endocrinol. 2015; 3 (1): 17-26.
2. Shah V, Shoskes A, Tawfik B, Garg S., Closed-loop system in the management of diabetes: past, present and future. Diabetes Technol Ther. 2014; 16 (8): 477-490.
3. Thabit H, Lubina-Solomon A, Stadler M, et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicenter, randomized crossover study. Lancet Diabetes Endocrinol. 2014; 2 (9): 701-709.
4. Breton M, Farre A, Bruttomesso D, et al. Fully integrated artificial pancreas in type 1 diabetes modular closed loop glucose control maintains near normoglycemia. Diabetes. 2012; 61: 2230-2237.
5. Castle J, Engle J, Youssef J, et al. Novel use of glucagon in a closed-loop system for prevention in hypoglycemia in type 1 diabetes. Diabetes Care. 2010; 33: 1282-1287.
6. Cobelli C, Renard E, Kovachev B., Artificial pancreas: past, present, future. Diabetes. 2011; 60: 2672-2682.
7. El-Khatib F, Russell S, Nathan D, Sutherlin R, Damiano E., A bio-hormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010; 4: 1374-1381.
8. Weinzimer S, Steil G, Swan K, Dziura J, Kurtz N, Tamborlane W., Fully automated closed loop control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008; 31: 934-939.
9. Hovorka R, Allen J, Elleri D, et al. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomized cross over trial. Lancet. 2010; 375: 743-751.
10. Atlas E, Nimri R, Miller S, Grunberg E, Phillip M., MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010; 33: 1072-1076.
11. Del Favero S, Place J, Kropff J, et al. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes Obes Metab. 2015; 17 (5): 468-476.
12. Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care. 2014; 37 (11): 3025-3032.
13. Ly T, Breton M, Keith-Hynes P, et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014; 37: 2310-2316.
14. Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013; 386: 824-933.
15. Ly T, Roy A, Grossman B, et al. Day and night closed loop control using the integrated Medtronic hybrid closed loop system in type 1 diabetes at diabetes camp. Diabetes Care. 2015; 38: 1205-1211.
16. Russell S, El-Khatib F, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014; 3714: 313-325.
17. Russell S, Hillard M, Balliro C, et al. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol. 2016; 4 (3): 233-243.
18. Barnard K, Hood K, Weissberg-Benchell J, Aldred C, Oliver N, Laffel L., Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP research. Diabetes Technol Ther. 2015; 17 (4): 295-300.
19. Van Bon A, Brouwer T, von Basum G, Hoekstra J, DeVries J,. Future acceptance of an artificial pancreas in adults with type 1 diabetes. Diabetes Technol Ther. 2011; 13 (7): 731-736.
20. Barnard K, Pinsker J, Oliver N, Astle A, Dassau E, Kerr D., Future artificial pancreas technology for type 1 diabetes: what do users want? Diabetes Technol Ther. 2015; 17 (5): 311-315.
21. Bevier W, Fuller S, Fuller R, et al. Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology. 2014; 16 (9): 590-595.
22. Russell S, Hilliard M, Balliro C, et al. Appendix for: outpatient glycemic control using a bionic pancreas in pre-adolescent children with type 1 diabetes. Lancet Diabetes Endocrinol. 2016.
23. Gonder-Frederick L, Nyer M, Shepard J, Vajda K, Clarke W., Assessing fear of hypoglycemia in children with type 1 diabetes and their parents. Diabetes Manage. 2011; 1 (6): 627-639.
24. Weissberg-Benchell J, Rychlik K., Assessing the impact of diabetes camp. Abstract presented at: 75th Scientific Sessions, American Diabetes Association; June 2015; Boston, MA.
25. Weissberg-Benchell J, Antisdel-Lomaglio J., Diabetes-specific emotional distress among adolescents: feasibility, reliability and validity of the problem areas in diabetes-teen version. Pediatr Diabetes. 2011; 12 (4): 341-344.
26. Weissberg-Benchell J, Rychlik K., Assessing the impact of camp. Abstract published from: 75th Annual Scientific Sessions, American Diabetes Association; 2015; Boston, MA.